-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TlPVYk53VRzPuQX4S7loyfdRiBgZxWdepI7SPXZX85VHXL9DY9xSlHkv6vKxN/9A +RsQKsm/5eKPoBAmKiA2Vg== 0000897101-07-000822.txt : 20070418 0000897101-07-000822.hdr.sgml : 20070418 20070418122238 ACCESSION NUMBER: 0000897101-07-000822 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070418 DATE AS OF CHANGE: 20070418 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: UROPLASTY INC CENTRAL INDEX KEY: 0000890846 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411719250 STATE OF INCORPORATION: MN FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-78417 FILM NUMBER: 07772801 BUSINESS ADDRESS: STREET 1: 5420 FELTL ROAD CITY: MINNETONKA STATE: MN ZIP: 55343 BUSINESS PHONE: (952) 426-6140 MAIL ADDRESS: STREET 1: 5420 FELTL ROAD CITY: MINNETONKA STATE: MN ZIP: 55343 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CystoMedix, Inc. CENTRAL INDEX KEY: 0001396679 IRS NUMBER: 411717730 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 1887 STATION PARKWAY NW STREET 2: BUILDING 7 CITY: ANDOVER STATE: MN ZIP: 55304 BUSINESS PHONE: (763) 427-6509 MAIL ADDRESS: STREET 1: 1887 STATION PARKWAY NW STREET 2: BUILDING 7 CITY: ANDOVER STATE: MN ZIP: 55304 SC 13G 1 cystomedix071710_13g.htm SCHEDULE 13G DATED APRIL 6, 2007 CystoMedix, Inc. Form SC13G dated April 6, 2007

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No.        )

Uroplasty, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

 

917277204

(CUSIP Number)

 

Frank I. Harvey, Esq.

Larkin Hoffman Daly & Lindgren

Wells Fargo Plaza, Suite 1500

7900 Xerxes Avenue S.

Minneapolis, MN 55431

(952) 835-3800

 

(Name, Address and Telephone Number of Person Authorized

to Receive Notices and Communications)

 

April 6, 2007

(Date of Event Which Requires Filing

of This Statement)

Check the following box if a fee is being paid with this statement [ ]

 

 

(Cover page continued on next page)

 



 

 

CUSIP No.   917277204  

 

13G

Page   2   of   5    Pages

 

1

NAME OF REPORTING PERSONS

I.R.S. Identification Nos. of above persons (entities only)

 

 

CystoMedix, Inc.
(EIN 41-1717730)

 

 

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

 

 

 

 

(a)   o

(b)   o

3

SEC USE ONLY

 

 

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Minnesota, U.S.A.

 

 

 

 

NUMBER OF

5

SOLE VOTING POWER

1,417,144

 

SHARES

BENEFICIALLY

OWNED BY

EACH

6

SHARED VOTING POWER

0

REPORTING

PERSON

WITH

7

SOLE DISPOSITIVE POWER

1,417,144

 

 

8

SHARED DISPOSITIVE POWER

0

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,417,144

 

 

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

 

o

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

10.88%

 

 

12

TYPE OF REPORTING PERSON*

CO

 

 

 

 



Item 1(a).    NAME OF ISSUER.

Uroplasty, Inc.

Item 1(b).  ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES.

5420 Feltl Road

Minnetonka, Minnesota 55343

Item 2(a).    NAME OF PERSON FILING.

CystoMedix, Inc.

Item 2(b).    ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE.

1887 Station Parkway NW

Building #7

Andover, MN 55304

Item 2(c).    CITIZENSHIP.

Minnesota, United States of America

Item 2(d).    TITLE OF CLASS OF SECURITIES.

Common Stock

Item 2(e).    CUSIP NO.

917277204

Item 3.    IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(b), OR 13D-2(b), CHECK WHETHER THE PERSON FILING IS A:

o

(a)

Broker or Dealer registered under Section 15 of the Act (15 U.S.C 78o).

o

(b)

Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).

o

(c)

Insurance Company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).

o

(d)

Investment Company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

o

(e)

An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

o

(f)

An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).

o

(g)

A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G)

 

3 of 5

 



o

(h)

A savings association as defined in Section 3(n) of the Federal Deposit Insurance Act (12 U.S.C. 1813).

o

(i)

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 89a-3).

o

(j)

Group, in accordance with §240.13d-1(b)(1)(ii)(J).

Not applicable.

Item 4.    OWNERSHIP.

 

The following information is provided as of April 16, 2007:

(a)

Amount Beneficially Owned:

1,417,144 shares

(b)

Percent of Class:

10.88%

(c)

Number of shares as to which such person has:

 

(i)

Sole power to vote or
to direct the vote:

1,417,144 shares

 

 

(ii)

Shared power to vote or
to direct the vote:

0

 

(iii)

Sole power to dispose or
to direct the disposition of:

1,417,144 shares

 

(iv)

Shared power to dispose or
to direct the disposition of:

0

Item 5.    OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o .

Item 6.    OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.

Not applicable.

Item 7.    IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.

Not applicable.

Item 8.    IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.

 

4 of 5

 



Not applicable.

Item 9.    NOTICE OF DISSOLUTION OF GROUP.

Not applicable.

Item 10.  CERTIFICATION.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having the purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated:   April 16, 2007

/s/   Jeffrey M. Williams

 

President and Chief Executive Officer

 

 















5 of 5

 


 -----END PRIVACY-ENHANCED MESSAGE-----